在三重阴性乳腺瘤小鼠模型中,作为向免疫治疗候选人的抗EGFR生物工程细菌外膜囊泡
Razieh Rezaei Adriani1, Seyed Latif Mousavi Gargari2, Hamid Bakherad3
1Department of Biology, Shahed University, Tehran, Iran.
Scientific reports
|September 29, 2023
概括
装有托尔类受体 (TLR) 激动剂的工程外膜囊泡 (OMV) 在克服对癌症免疫疗法的抵抗方面表现有前途. 这些向的纳米颗粒激活瘤微环境中的免疫细胞,增强抗癌反应.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 癌症免疫疗法,特别是检查点抑制剂,面临的挑战是患者无反应率 (55-87%).
- 对于提高非响应性癌症患者的治疗疗效的策略有着至关重要的需求.
研究的目的:
- 开发一种协同的癌症治疗方法,使用携带托尔类受体 (TLR) 激动剂的向纳米粒子.
- 设计生物衍生外膜囊泡 (OMVs) 以在瘤微环境中进行向的输送和免疫激活.
主要方法:
- 外膜囊泡 (OMVs) 是从グラム阴性细菌中设计的,以向过度表达表皮生长因子受体 (EGFR) 的癌细胞.
- 基于亲和力的测试被用来确定目标部分的结合亲和力.
- 在体外和体内研究中,使用EGFR过度表达的癌细胞和三阴性乳腺癌小鼠模型进行了实验.
主要成果:
- 工程OMV在体外表现出对EGFR过度表达的癌细胞的特异性坚持.
- 在体内给药OMV激活了自然杀手细胞,并在瘤微环境中促进了M2到M1巨细胞的两极分化.
- 内和内两种OMV的使用都显示出治疗潜力.
结论:
- 携带TLR激动剂的向OMV代表了增强癌症免疫治疗疗效的有希望的策略.
- 这种方法有效地激活先天免疫细胞并调节瘤微环境.
- OMVs为克服对当前癌症治疗方法的耐药性提供了一个潜在的平台.
相关概念视频
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


